Alopecia areata
RecruitingA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
- Disease:Alopecia areata
- Substances:–
Spain- Participants:18–64 years
- Sponsor:Almirall S.A.
Rare diseases
Investigational molecules
Locations
Back to Spain313 clinical trials in Alicante, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on advanced treatments for non-small cell lung cancer, including both early-stage and metastatic cases. Investigations are ongoing in acute myeloid leukemia and lymphoma treatments.
Research emphasizes innovative combination therapies and targeted treatments for better patient outcomes.
Comprehensive research into treatments for plaque psoriasis and atopic dermatitis, with multiple trials evaluating new therapeutic approaches for moderate to severe cases.
Studies focus on developing effective solutions for chronic skin conditions.
Investigations into hypertrophic cardiomyopathy and post-heart attack treatments, including studies on specialized stent therapies and antiplatelet medications.
Focus on improving outcomes for patients with various cardiac conditions.
Clinical trials examining treatments for allergic rhinoconjunctivitis and responses to various allergens, including specialized immunotherapy approaches.
Research aims to improve allergy management and treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.